Provectus Biopharmaceuticals Announces Publication of Activity of Pharmaceutical-Grade Rose Bengal Sodium Against Colistin-Resistant Gram-Negative Bacteria - Yahoo Finance

PVCTDelisted Stock  USD 0.11  0.00  0.00%   
Slightly above 56% of Provectus Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading Provectus Biopharmaceuticals otc stock suggests that many investors are alarmed at this time. Provectus Biopharmaceutica's investing sentiment can be driven by a variety of factors including economic data, Provectus Biopharmaceutica's earnings reports, geopolitical events, and overall market trends.
  
Provectus Biopharmaceuticals Announces Publication of Activity of Pharmaceutical-Grade Rose Bengal Sodium Against Colistin-Resistant Gram-Negative Bacteria Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Provectus Biopharmaceutica Fundamental Analysis

We analyze Provectus Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Provectus Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Provectus Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Z Score

Z Score Comparative Analysis

Provectus Biopharmaceutica is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Provectus Biopharmaceutica Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Provectus Biopharmaceutica otc stock to make a market-neutral strategy. Peer analysis of Provectus Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Provectus Biopharmaceutica by comparing valuation metrics with similar companies.

Peers

Provectus Biopharmaceutica Related Equities

ACXPAcurx Pharmaceuticals   22.47   
0%
100.0%
MLYSMineralys Therapeutics,   1.18   
0%
5.0%
AVTEAerovate Therapeutics   0.75   
0%
3.0%
CLDXCelldex Therapeutics   0.86   
3.0%
0%
KNSAKiniksa Pharmaceuticals   1.43   
6.0%
0%
NKTXNkarta   1.60   
7.0%
0%
IKNAIkena Oncology   1.78   
7.0%
0%
CYCCCyclacel Pharmaceuticals   2.17   
9.0%
0%
NGENFNervGen Pharma   2.73   
12.0%
0%
KZRKezar Life   3.06   
13.0%
0%
TARAProtara Therapeutics   4.72   
21.0%
0%
CRNXCrinetics Pharmaceuticals   5.00   
22.0%
0%
SRRKScholar Rock   5.11   
22.0%
0%
IPSCCentury Therapeutics   5.41   
24.0%
0%
XLOXilio Development   8.18   
36.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Provectus OTC Stock

If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account